Professor Idit Maya, a senior physician and manager of the Nephrogenetic Clinic and Genomic School for Physicians at Rabin ...
Oncocyte progresses towards FDA authorization for its transplant rejection monitoring test, with top U.S. centers participating in the trial. Oncocyte Corp. has made significant progress in preparing ...
Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kits Head-to-head comparison of iMDx’s digital PCR-based test kits with NGS kits shows consistent ...
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value ...